Phase 4 Nephropathy Clinical Trials
14 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–14 of 14 trials
Recruiting
Phase 4
Efficacy and Safety of Finerenone in Patients With Primary Membranous Nephropathy
Primary Membranous Nephropathy
First Affiliated Hospital, Sun Yat-Sen University116 enrolled1 locationNCT06573411
Recruiting
Phase 4
Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis
Kidney TransplantFocal Segmental GlomerulosclerosisProteinuria+1 more
Travere Therapeutics, Inc.20 enrolled9 locationsNCT07219121
Recruiting
Phase 4
Rivaroxaban in Idiopathic Membranous Nephropathy
Idiopathic Membranous Nephropathy
Beijing Friendship Hospital134 enrolled1 locationNCT07404436
Recruiting
Phase 4
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
IgA Nephropathy
Calliditas Therapeutics AB60 enrolled38 locationsNCT06712407
Recruiting
Phase 4
ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases
Chronic Kidney DiseaseDiabetic NephropathiesChronic Kidney Disease (Stages 4 and 5)+5 more
Ace Cells Lab Limited300 enrolled1 locationNCT07187713
Recruiting
Phase 4
Nefecon and Ambrisentan in IgA Nephropathy
Chronic Kidney DiseaseIgA NephropathyProteinuria
The First Hospital of Jilin University129 enrolled1 locationNCT07030894
Recruiting
Phase 4
Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?
IgA NephropathyRenal Insufficiency, ChronicIgA Vasculitis+1 more
Christian Medical College, Vellore, India585 enrolled12 locationsNCT06676384
Recruiting
Phase 4
Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.
GlomerulonephritisImmunoglobulin A Nephropathy
Fondazione Schena878 enrolled2 locationsNCT04662723
Recruiting
Phase 4
Albuminuria Lowering Effect of Dapagliflozin, Spironolactone and Their Combination in Adult Patients with Alport Syndrome (COMBINE-ALPORT)
Alport SyndromeThin Basement Membrane DiseaseAlport Nephropathy
Stefan Lujinschi34 enrolled1 locationNCT06499948
Recruiting
Phase 4
Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy
NephropathyGlomerular DiseasesIdiopathic Membranous Nephropathy
Chinese PLA General Hospital480 enrolled1 locationNCT05839314
Not Yet Recruiting
Phase 4
FAN Trial: A randomised controlled open label trial assessing the effect of perindopril erbumine on Fontan-Associated Nephropathy
Fontan Associated NephropathySingle Ventricle
Australian Heart Foundation50 enrolled1 locationACTRN12624000648527
Recruiting
Phase 4
Clinical Study of Rituximab Combined With Corticosteroids or Rituximab Monotherapy in the Treatment of Primary Membranous Nephropathy
Primary Membranous Nephropathy
First Affiliated Hospital, Sun Yat-Sen University78 enrolled1 locationNCT05514015
Recruiting
Phase 4
Intravenous Contrast Computed Tomography Versus Native Computed Tomography in Patients With Acute Abdomen and Impaired Renal Function
Acute AbdomenRadiocontrast Nephropathy
Helsinki University Central Hospital994 enrolled3 locationsNCT04196244
Completed
Phase 4
Randomized prospective trial of cyclosporine with/without low-dose prednisolone in idiopathic membranous nephropathy in adults with nephrotic syndrome
idiopathic membranous nephropathy with nephrotic syndrome
Research Group for Treatments of Kidney Diseases in Ibaraki, Japan30 enrolled1 locationACTRN12609000996268